Product information

Current status:

Cancelled Post Market

Current status date:

2005-08-10

Original market date: ^{See footnote 1}

1968-12-31

Product name:

NOVO-POXIDE 10MG

DIN:

00020923 Electronic product monograph is not available

Company:

NOVOPHARM LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

TARGETED SUBSTANCES (CDSA IV)

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:24.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N05BA02 CHLORDIAZEPOXIDE

Active ingredient group (AIG) number:^{See footnote5}

0100613001